ANTX

Conviction 80HealthcareScan · Thu, Jun 25, 2026

ANTX$5.14-1.15%

ResistanceSupportVol 14Insider sell

Vol MA14 283.04K

Mar 26Apr 14May 1May 19Jun 8Jun 25

AN2 Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.an2therapeutics.com ↗

Price5.14

Change-1.15%

Gap+0.58%

Rel volume0.70×

Avg volume253.19K

Avg $ vol1.19M

SMA 204.54

SMA 504.46

SMA 2002.36

Price vs 50+15.32%

Price vs 200+117.55%

MA stackbullish

50/200 cross—

Supertrendup · 3.92

RSI (14)60

MACD hist0.08

MACD crossbull · 8d

Stoch %K / %D80 / 78

ADX (14)17

+DI / −DI23 / 18

RSI divergence—

MACD divergence—

ATR %+8.21%

ADR %8.94%

52w high5.46

52w low1.03

From 52w high-5.86%

Above 52w low+399.03%

New 52w highNo

SqueezeOff

Bollinger width41.57%

%B0.82

Donchian pos79.56%

Donchian high5.51

Donchian low3.70

AVWAP (52w high)4.84

vs AVWAP high+6.23%

AVWAP (52w low)4.45

vs AVWAP low+15.46%

OBV trendUp

Chaikin MF (20)-0.07

Today vs 20d0.70×

Avg vol (14d)283.04K

Avg vol (20d)253.19K

Avg $ vol (20d)1.19M

Market cap185.12M

RS 3m (vs SPY)+25.67%

RS 6m (vs SPY)+356.55%

RS line new highNo

Trend template8/8

Technical rank90.7

1 week+4.90%

1 month+8.67%

3 months+40.44%

6 months+363.06%

1 year+375.93%

YTD+363.06%

P/E-5.26

P/B2.26

P/S—

P/FCF—

EPS-1.16

Div yield—

ROE-43.02%

ROA-40.20%

Debt/Eq—

Current15.73

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth31.46%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value131.64M

Revenue—

Net income-10.03M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.02M

Employees21

ListedFri, Mar 25, 2022

Free float25.94M

Float %72.2%

Short interest1.21M

Days to cover5.4d

Short volume67.2%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank90.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.37

Support3.82

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANTX

All disclosures →

No recent disclosed trades by Congress in ANTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANTX · 3 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Williams Sarah Joanne Principal Accounting Officer · Common Stock · 2026-05-29	Sell	265	$1K	2026-05-29	2026-06-02
Aziz Kabeer Director · Common Stock · 2026-04-10	Grant	3.77K	$0	2026-04-10	2026-04-10
Marks Gilbert Lynn Director · Common Stock · 2026-04-10	Grant	3.77K	$0	2026-04-10	2026-04-10
Aziz Kabeer Director · Common Stock · 2026-04-10	Other	—	—	2026-04-10	2026-04-10
Martin Patricia A. Director · Common Stock · 2026-04-10	Grant	1.19K	$0	2026-04-10	2026-04-10

SEC filings

EDGAR filings in ANTX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.